Adcon Capital (539506)
Asset PlayScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹0.83 |
| Market Cap | ₹40.47 Cr |
| P/E Ratio | 6.18 |
| ROCE | 8.3% |
| ROE | 4.1% |
| Dividend Yield | 0% |
| Profit Growth | -72.73% |
| Debt/Equity | — |
| Sales Growth | 5.08% |
| 52-Week Range | ₹0.4 — ₹1.05 |
| Sector | Finance |
| Book Value | ₹1.02 |
Strengths
- Trading at P/B of 0.81, a 19% discount to book value of ₹1.02
- Low headline P/E of 6.18, though distorted by collapsing profits
- Modest sales growth of 5.08% shows some business activity
- Positive book value and a small, niche NBFC structure
- ROCE of 8.30% is better than ROE, suggesting operating assets generate some return
Concerns
- Profit growth down 72.73%, with latest quarter net profit at ₹0 Cr
- ROE of just 4.10% signals weak shareholder value creation
- Piotroski F-Score of 4/9 indicates poor financial health
- No dividend, no promoter holding data, and debt/equity not disclosed — insufficient transparency for a leveraged lender
AI Analysis
When I look at Adcon Capital, the first thing I see is a stock selling at ₹0.83 against a book value of ₹1.02 — a 19% discount to book. But as Graham taught, a discount to book is only a starting point, not a conclusion. This is a thinly capitalised NBFC with a market cap of just ₹40 Cr. ROE is 4.10%, barely what a bank deposit would give, and ROCE is 8.30%. The latest quarter tells the real story: sales of ₹1 Cr and net profit of essentially ₹0 Cr. Profit growth has collapsed by 72.73% even though sales grew 5.08% — that means margins are under severe pressure or there is a serious one-off hit. The Piotroski F-Score of 4/9 confirms weak fundamentals. There is no dividend, so shareholder return depends entirely on asset quality and capital allocation. Debt/Equity is N/A, and for a lending business that is a red flag, not an omission — leverage is the raw material of an NBFC. PEG of 1.22 looks optically cheap, but only if profits recover. With the latest quarter at break-even, I see no evidence of that. This is not a wonderful business; it is a small financial firm trading below book because the market sees poor return on equity. I would only view it as an asset play, and even then, only if management can prove the loan book is sound and eventually earn more than its cost of capital. In Buffett's words, it is far better to buy a wonderful company at a fair price. Adcon, at any price, does not yet pass that test.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer